Astellas, Endo issue US drug recalls over empty capsule, ingredient concerns
3rd January 2025 Uncategorised 0Astellas Pharma and Endo subsidiary Endo USA issued voluntary recalls for products they manufacture over concerns of empty tablets and unapproved ingredients, respectively. More: Astellas, Endo issue US drug recalls over empty capsule, ingredient concerns Source: fierce
read more